诱导疗法对免疫学风险方面的移植功能的影响
Ahmet Ziya Şahin1, Orhan Özdemir2, Özlem Usalan1
1Department of Nephrology, Gaziantep University School of Medicine, Gaziantep, Turkey.
Transplantation proceedings
|July 6, 2023
概括
移植后的一年,具有高免疫风险的移植接受者表现出类似的移植功能和存活率,无论诱导疗法如何. 对高风险患者来说,低剂量抗胆小细胞球蛋白与巴西利西马布结合似乎是有希望的.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 移植 移植 移植 移植
背景情况:
- 由于免疫抑制和手术技术的进步,移植的结果有所改善.
- 免疫风险分层对于指导移植患者的诱导疗法选择至关重要.
- 评估移植功能包括监测血清肌素,CKD-EPI,蛋白尿和CMV和BK病毒等传染性标志物.
研究的目的:
- 为了比较低和高免疫风险移植患者之间的移植功能.
- 评估移植功能标志物,包括肌素,CKD-EPI,蛋白尿和病毒PCR阳性.
- 评估不同诱导疗法对一年的移植存活率和并发症的影响.
主要方法:
- 对80名移植接受者的回顾性研究.
- 患者分为低免疫风险 (仅巴西利克西马布) 和高免疫风险 (低剂量抗甲基球蛋白+巴西利克西马布) 组.
- 在多个时间点通过肌素,CKD-EPI,蛋白尿,白血病,CMV PCR和BK病毒PCR评估移植功能.
主要成果:
- 在1,3,6和12个月的风险组之间,肌素,CKD-EPI或蛋白尿水平没有显著差异.
- 在两组中观察到类似的白血病和CMV/BK病毒PCR阳性的频率.
- 低免疫风险组和高免疫风险组之间的1年移植存活率没有显著差异.
结论:
- 高风险移植患者的诱导治疗方案与低风险患者相比,没有显著影响一年的移植存活率.
- 联合低剂量抗胆小细胞球蛋白和巴西利克西马布显示出管理高风险患者的潜力,在移植存活率和感染标志物方面具有良好的结果.
- 需要进一步的研究来证实这种联合诱导疗法的长期疗效和安全性.
更多相关视频
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
14.6K
09:50Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
Published on: February 11, 2019
9.8K
相关概念视频
01:40Cell-mediated Immune Responses
69.1K
Overview
69.1K
01:28Kidney Transplant I: Introduction
29
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
29
01:24Tissue Transplantation
415
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
415
01:22Bone Marrow Sampling and Transplants
363
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
363